Gennari A - Search Results

1

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.

Gennari A, Sormani MP, Pronzato P, Puntoni M, Colozza M, Pfeffer U, Bruzzi P. Gennari A, et al. J Natl Cancer Inst. 2008 Jan 2;100(1):14-20. doi: 10.1093/jnci/djm252. Epub 2007 Dec 25. J Natl Cancer Inst. 2008. PMID: 18159072

2

Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors.

Gennari A, Salvadori B, Donati S, Bengala C, Orlandini C, Danesi R, Del Tacca M, Bruzzi P, Conte PF. Gennari A, et al. J Clin Oncol. 1999 Nov;17(11):3596-602. doi: 10.1200/JCO.1999.17.11.3596. J Clin Oncol. 1999. PMID: 10550159 Clinical Trial.

3

Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.

Gennari A, Donati S, Salvadori B, Giorgetti A, Salvadori PA, Sorace O, Puccini G, Pisani P, Poli M, Dani D, Landucci E, Mariani G, Conte PF. Gennari A, et al. Clin Breast Cancer. 2000 Jul;1(2):156-61; discussion 162-3. doi: 10.3816/cbc.2000.n.014. Clin Breast Cancer. 2000. PMID: 11899654

4

Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.

Gennari A, Guarneri V, Landucci E, Orlandini C, Rondini M, Salvadori B, Ricci S, Conte PF. Gennari A, et al. Clin Breast Cancer. 2002 Dec;3(5):346-52. doi: 10.3816/CBC.2002.n.038. Clin Breast Cancer. 2002. PMID: 12533265 Clinical Trial.

5

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.

Gennari A, Bruzzi P, Orlandini C, Salvadori B, Donati S, Landucci E, Guarneri V, Rondini M, Ricci S, Conte P. Gennari A, et al. Br J Cancer. 2004 Mar 8;90(5):962-7. doi: 10.1038/sj.bjc.6601634. Br J Cancer. 2004. PMID: 14997190 Free PMC article.

6

Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies.

Gennari A, Conte P, Rosso R, Orlandini C, Bruzzi P. Gennari A, et al. Cancer. 2005 Oct 15;104(8):1742-50. doi: 10.1002/cncr.21359. Cancer. 2005. PMID: 16149088 Free article.

7

Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.

Gennari A, Amadori D, De Lena M, Nanni O, Bruzzi P, Lorusso V, Manzione L, Conte PF. Gennari A, et al. J Clin Oncol. 2006 Aug 20;24(24):3912-8. doi: 10.1200/JCO.2006.06.1812. J Clin Oncol. 2006. PMID: 16921042 Clinical Trial.

8

Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer.

Gennari A, De Tursi M, Carella C, Ricevuto E, Orlandini C, Frassoldati A, Conte P, Bruzzi P, Iacobelli S. Gennari A, et al. Breast Cancer Res Treat. 2009 May;115(1):131-6. doi: 10.1007/s10549-008-0048-8. Epub 2008 Sep 13. Breast Cancer Res Treat. 2009. PMID: 18791821 Clinical Trial.

9

New understanding of the role of anthracyclines in early-stage breast cancer: patient selection considerations.

Gennari A, Pronzato P. Gennari A, et al. Clin Breast Cancer. 2008 Dec;8 Suppl 4:S179-83. doi: 10.3816/CBC.2008.s.015. Clin Breast Cancer. 2008. PMID: 19158039 Review.

10

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S. Decensi A, et al. Among authors: gennari a. Cancer Prev Res (Phila). 2010 Nov;3(11):1451-61. doi: 10.1158/1940-6207.CAPR-10-0157. Epub 2010 Oct 12. Cancer Prev Res (Phila). 2010. PMID: 20947488 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page